PAR DRUGS AND CHEMICALS
|
|
BOM :      NSE : PAR     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : NA |
Sep 06,2024 |
Price(EOD): ₹ 237.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 291.76 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
PAR DRUGS AND CHEMICALS | -4.8% | 1.4% | 28.1% |
PIDILITE INDUSTRIES | 2.4% | 2.6% | 28.3% |
SOLAR INDUSTRIES INDIA | -0.6% | 7.7% | 128.5% |
SRF | -3.1% | -3.1% | 9.8% |
GUJARAT FLUOROCHEMICALS | 20% | 15% | 14.8% |
DEEPAK NITRITE | 0.7% | -5.5% | 34.8% |
FUNDAMENTAL ANALYSIS OF PAR DRUGS AND CHEMICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF PAR DRUGS AND CHEMICALS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
20.04
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 14.56 Cr
[Latest Qtr - Jun2024 - Standalone Results ] 3.41
P/B Calculated based on Book Value of Rs 85.63 Cr
[Latest Year - Mar2024 - Standalone Results ] 3.06
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
212% 168% 96% |
SHARE PRICE MOMENTUM OF PAR DRUGS AND CHEMICALS
PAR DRUGS AND CHEMICALS vs SENSEX
DEBT OF PAR DRUGS AND CHEMICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0 0 0.16 0.05 |
- - - - |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF PAR DRUGS AND CHEMICALS
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF PAR DRUGS AND CHEMICALS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-0.93% -30.49% -33.75% -31.9% |
-1.43% 2.47% 2.61% 2.59% |
QtrlyTrend |
-2 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
PAR DRUGS AND CHEMICALS related INDICES
You may also like the below Video Courses
FAQ about PAR DRUGS AND CHEMICALS
Is PAR DRUGS AND CHEMICALS good for long term investment?
As on Sep 06,2024, the Fundamentals of PAR DRUGS AND CHEMICALS look Strong and hence it may be good for long term investment! See Financial Performance of PAR DRUGS AND CHEMICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is PAR DRUGS AND CHEMICALS UnderValued or OverValued?
As on Sep 06,2024, PAR DRUGS AND CHEMICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of PAR DRUGS AND CHEMICALS ?
As on Sep 06,2024, the Intrinsic Value of PAR DRUGS AND CHEMICALS is Rs. 88.62 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 76.07
Fair Value [Median EV / Sales Model] : Rs. 88.62
Fair Value [Median Price / Sales Model] : Rs. 120.82
Estimated Median Fair Value of PAR DRUGS AND CHEMICALS : Rs. 88.62
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is PAR DRUGS AND CHEMICALS trading at a Premium or Discount?
As on Sep 06,2024, PAR DRUGS AND CHEMICALS is trading at a Premium of 168% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs TATA CHEMICALS LTD